Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Organon & Co.OGN · Entity 4115 | Head of Mfg & Supply | August 05, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Organon & Co.
Report date August 05, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,474.703 |
Reported balance
After 2026-08-05 transaction · row 1
1 source rowRow 1 · 2026-08-05 · Sale · Disposed 14,761 · Balance 18,474.703 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 5, 2026 20:04 UTC | Organon & Co. OGN · Entity 4115 | SaleCommon Stock | 14,761 | $13.57 | $200,306.77 |
DisclosureSEC source: 0001628280-26-053306 · wk-form4_1785960273.xml · nonDerivative · entry 1 Drinane Juliana Papa · CIK 0002096406 · Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,474.703 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:26 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 10,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023209 · wk-form4_1775161569.xml · derivative · entry 7 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,148 Underlying: Common Stock · 10,073 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Organon common stock. F5 · derivative.exercise_date: On March 31, 2025, the Reporting Person was granted 30,221 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028. F5 · derivative.expiration_date: On March 31, 2025, the Reporting Person was granted 30,221 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:26 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 6,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023209 · wk-form4_1775161569.xml · derivative · entry 6 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,378 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Organon common stock. F4 · derivative.exercise_date: On March 31, 2023, the Reporting Person was granted 19,132 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. F4 · derivative.expiration_date: On March 31, 2023, the Reporting Person was granted 19,132 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:26 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 125,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023209 · wk-form4_1775161569.xml · derivative · entry 5 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,208 Underlying: Common Stock · 125,208 shares Expires not disclosed F2 · derivative.exercise_price: On March 31, 2026, the Reporting Person was granted 125,208 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. F2 · derivative.exercise_date: On March 31, 2026, the Reporting Person was granted 125,208 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. F2 · derivative.expiration_date: On March 31, 2026, the Reporting Person was granted 125,208 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:26 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 3,451 | $5.70 | $19,670.70 |
DisclosureSEC source: 0001628280-26-023209 · wk-form4_1775161569.xml · nonDerivative · entry 4 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,235.703 F1 · price: This price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:26 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 10,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023209 · wk-form4_1775161569.xml · nonDerivative · entry 3 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,686.703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:26 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 2,185 | $5.70 | $12,454.50 |
DisclosureSEC source: 0001628280-26-023209 · wk-form4_1775161569.xml · nonDerivative · entry 2 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,613.703 F1 · price: This price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:26 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 6,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023209 · wk-form4_1775161569.xml · nonDerivative · entry 1 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,798.703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2026 Filed Mar 31, 2026 20:10 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 7,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-022397 · wk-form4_1774987834.xml · derivative · entry 3 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,979 Underlying: Common Stock · 7,979 shares Expires 2027-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Organon common stock. F3 · derivative.exercise_date: These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027. F3 · derivative.expiration_date: These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027. Read SEC document |
| March 29, 2026 Filed Mar 31, 2026 20:10 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 2,733 | $5.84 | $15,960.72 |
DisclosureSEC source: 0001628280-26-022397 · wk-form4_1774987834.xml · nonDerivative · entry 2 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,420.703 F1 · price: This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. Read SEC document |
| March 29, 2026 Filed Mar 31, 2026 20:10 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 7,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-022397 · wk-form4_1774987834.xml · nonDerivative · entry 1 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,153.703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 21:05 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 65,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-052592 · wk-form4_1763413497.xml · derivative · entry 1 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,616 Underlying: Common Stock · 65,616 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") converts into one share of Organon & Co. common stock. F2 · derivative.exercise_date: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On November 13, 2025, RSUs were granted and will vest in three equal installments on each of November 13, 2026, November 13, 2027, and November 13, 2028. F2 · derivative.expiration_date: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On November 13, 2025, RSUs were granted and will vest in three equal installments on each of November 13, 2026, November 13, 2027, and November 13, 2028. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:48 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 3,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-051733 · wk-form4_1762987721.xml · derivative · entry 3 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,626 Underlying: Common Stock · 3,626 shares Expires 2026-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Organon & Co. F2 · derivative.exercise_date: 10,876 restricted stock units ("RSUs") were granted on November 7, 2023, and one-third vest each year with the final vesting date being November 7, 2026. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:48 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 1,242 | $6.71 | $8,333.82 |
DisclosureSEC source: 0001628280-25-051733 · wk-form4_1762987721.xml · nonDerivative · entry 2 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,658.703 Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 22:48 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 3,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-051733 · wk-form4_1762987721.xml · nonDerivative · entry 1 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,416.703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2025 Filed Jan 16, 2026 21:37 UTC Amendment | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 1,242 | $6.71 | $8,333.82 |
DisclosureSEC source: 0001628280-26-002406 · wk-form4a_1768599463.xml · nonDerivative · entry 1 Drinane Juliana Papa · CIK 0002096406 · Interim Head of Mfg & Supply 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,174.703 F1 · balance_after: On November 12, 2025, the reporting person filed a Form 4 which inadvertently reported that she acquired (A) 1,242 shares of Organon & Co. (Organon) common stock due to the sale of shares to satisfy a tax liability related to the acquisition of other shares of Organon common stock (code F), where in fact this number of shares should have been reported as a transaction resulting in her disposal (D) of such shares to satisfy the tax liability. As a result, the total amount of securities beneficially owned by the reporting person following such sale transaction on November 7, 2025, is now correctly reported on this Form 4 in column 5 as 17,174.703. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.